Correlation Engine 2.0
Clear Search sequence regions


  • alleles (1)
  • bed ridden (1)
  • brain (1)
  • cognitive (1)
  • exon (2)
  • female (1)
  • humans (1)
  • infant (1)
  • intron (2)
  • korean (1)
  • patient (1)
  • POLR3 (5)
  • POLR3A (7)
  • proband (1)
  • protein human (1)
  • rna polymerase (2)
  • Sizes of these terms reflect their relevance to your search.

    Hypomyelinating POLR3-related leukodystrophy is a group of rare neurological diseases characterized by degeneration of the white matter of the brain with different combinations of major clinical findings. Here we report the first Korean POLR3-related leukodystrophy caused by bi-allelic POLR3A c.1771-6C > G and novel c.1650_1661del variants. An 18-month-old girl was admitted for evaluation of a seizure-like activity with spasticity that affected her entire body. She showed dental abnormalities, but not suspicious facial dysmorphism. She was in a bed-ridden state with severe cognitive impairments and episodes of dystonic posturing for 1-2 min. Trio exome sequencing (ES) was performed to determine the potential genetic cause of severe developmental delay with leukodystrophy in our proband. Trio ES revealed that bi-allelic POLR3A deleterious variants, c.1650_1661del of the exon 13, and c.1771-6C > G of the intron 13 were best candidate as causes of hypomyelinating POLR3-related leukodystrophy. Sanger sequencing confirmed the genetic origin of these POLR3A deleterious variants as autosomal recessive hereditary transmission. Our report provides additional evidence for a phenotypic continuum of hypomyelinating POLR3-related leukodystrophy caused by bi-allelic POLR3A variants. Further genetic studies are required to understand underlying pleiotropic effects of different POLR3A variants. Copyright © 2022 Elsevier B.V. All rights reserved.

    Citation

    Ji Yoon Han, Yong Gon Cho, Joonhong Park, Woori Jang. A novel variant of the POLR3A gene in a patient with hypomyelinating POLR3-related leukodystrophy. Clinica chimica acta; international journal of clinical chemistry. 2022 Aug 01;533:15-21

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35691411

    View Full Text